- Home
- XCUR vs CCEL Comparison
XCUR vs CCEL Comparison
Compare XCUR & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XCUR
- CCEL
- Stock Information
- Founded
- XCUR 2011
- CCEL 1989
- Country
- XCUR United States
- CCEL United States
- Employees
- XCUR N/A
- CCEL N/A
- Industry
- XCUR Biotechnology: Pharmaceutical Preparations
- CCEL Managed Health Care
- Sector
- XCUR Health Care
- CCEL Health Care
- Exchange
- XCUR Nasdaq
- CCEL Nasdaq
- Market Cap
- XCUR 32.4M
- CCEL 34.8M
- IPO Year
- XCUR N/A
- CCEL 1997
- Fundamental
- Price
- XCUR $3.88
- CCEL $4.52
- Analyst Decision
- XCUR
- CCEL Strong Buy
- Analyst Count
- XCUR 0
- CCEL 1
- Target Price
- XCUR N/A
- CCEL $8.50
- AVG Volume (30 Days)
- XCUR 27.1K
- CCEL 27.1K
- Earning Date
- XCUR 11-13-2025
- CCEL 10-14-2025
- Dividend Yield
- XCUR N/A
- CCEL 13.27%
- EPS Growth
- XCUR N/A
- CCEL N/A
- EPS
- XCUR N/A
- CCEL N/A
- Revenue
- XCUR N/A
- CCEL $31,988,783.00
- Revenue This Year
- XCUR N/A
- CCEL $1.75
- Revenue Next Year
- XCUR N/A
- CCEL N/A
- P/E Ratio
- XCUR N/A
- CCEL N/A
- Revenue Growth
- XCUR N/A
- CCEL 1.10
- 52 Week Low
- XCUR $1.44
- CCEL $4.09
- 52 Week High
- XCUR $36.00
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- XCUR 23.53
- CCEL 47.44
- Support Level
- XCUR $3.10
- CCEL $4.20
- Resistance Level
- XCUR $7.06
- CCEL $4.64
- Average True Range (ATR)
- XCUR 0.38
- CCEL 0.22
- MACD
- XCUR -0.15
- CCEL 0.01
- Stochastic Oscillator
- XCUR 25.06
- CCEL 51.61
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.